Skip to main content
Journal cover image

Onset and recovery of neuromuscular blockade after two doses of rocuronium in children.

Publication ,  Journal Article
Ross, AK; Dear, GL; Dear, RB; Margolis, JO; Ginsberg, B
Published in: J Clin Anesth
December 1998

STUDY OBJECTIVE: To determine if 450 micrograms/kg (1.5 times the ED95) of rocuronium would result in a comparable onset with a shorter duration of action when compared with 600 micrograms/kg (2 times the ED95). DESIGN: Randomized, single-blind study. SETTING: Teaching hospital. PATIENTS: 85 ASA physical status I and II children ages 2 through 12, undergoing elective surgery with an inhalation induction using halothane. INTERVENTIONS: Group 1 received 600 micrograms/kg rocuronium, and Group 2 received 450 micrograms/kg rocuronium. MEASUREMENTS AND MAIN RESULTS: The two groups were compared using a Student's t-test, with p < 0.05 significant. The time of onset, or time to 95% suppression of neuromuscular twitch with standard errors, was 140 +/- 13 seconds (range 46 to 365 sec) in Group 1 and 148 +/- 13 seconds (range 82 to 345 sec) in Group 2 (NS = not significant). The times to 25% return of twitch from baseline (T25) in Groups 1 and 2 were 28 +/- 1.5 minutes (range 14 to 45 min) and 26 +/- 1.6 minutes (range 10 to 55 min), respectively (NS). The differences between these two doses in onset of, and recovery from, block were not found to be statistically significant. The results, however, excluded 5% of the higher dose group and 31% of the lower dose group who did not achieve 95% suppression of twitch. Time to maximal suppression of neuromuscular blockade, however, was not statistically significant for the 85 patients with a time of 270 +/- 28 seconds (range 91 to 605 sec) with a mean maximal suppression of 98.7% in Group 1 and 313 +/- 25 seconds (range 91 to 899 sec) with a mean maximal suppression of 93.1% in Group 2. CONCLUSION: The two doses of rocuronium did not differ statistically in onset or duration. Rocuronium at 600 micrograms/kg offers more reliability than 450 micrograms/kg in achieving adequate muscle relaxation, and the lower dose may result in a significantly large number of patients who may have inadequate intubating conditions.

Duke Scholars

Published In

J Clin Anesth

DOI

ISSN

0952-8180

Publication Date

December 1998

Volume

10

Issue

8

Start / End Page

631 / 635

Location

United States

Related Subject Headings

  • Ulnar Nerve
  • Time Factors
  • Single-Blind Method
  • Rocuronium
  • Reproducibility of Results
  • Neuromuscular Nondepolarizing Agents
  • Neuromuscular Junction
  • Neuromuscular Blockade
  • Muscle Contraction
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ross, A. K., Dear, G. L., Dear, R. B., Margolis, J. O., & Ginsberg, B. (1998). Onset and recovery of neuromuscular blockade after two doses of rocuronium in children. J Clin Anesth, 10(8), 631–635. https://doi.org/10.1016/s0952-8180(98)00098-1
Ross, A. K., G. L. Dear, R. B. Dear, J. O. Margolis, and B. Ginsberg. “Onset and recovery of neuromuscular blockade after two doses of rocuronium in children.J Clin Anesth 10, no. 8 (December 1998): 631–35. https://doi.org/10.1016/s0952-8180(98)00098-1.
Ross AK, Dear GL, Dear RB, Margolis JO, Ginsberg B. Onset and recovery of neuromuscular blockade after two doses of rocuronium in children. J Clin Anesth. 1998 Dec;10(8):631–5.
Ross, A. K., et al. “Onset and recovery of neuromuscular blockade after two doses of rocuronium in children.J Clin Anesth, vol. 10, no. 8, Dec. 1998, pp. 631–35. Pubmed, doi:10.1016/s0952-8180(98)00098-1.
Ross AK, Dear GL, Dear RB, Margolis JO, Ginsberg B. Onset and recovery of neuromuscular blockade after two doses of rocuronium in children. J Clin Anesth. 1998 Dec;10(8):631–635.
Journal cover image

Published In

J Clin Anesth

DOI

ISSN

0952-8180

Publication Date

December 1998

Volume

10

Issue

8

Start / End Page

631 / 635

Location

United States

Related Subject Headings

  • Ulnar Nerve
  • Time Factors
  • Single-Blind Method
  • Rocuronium
  • Reproducibility of Results
  • Neuromuscular Nondepolarizing Agents
  • Neuromuscular Junction
  • Neuromuscular Blockade
  • Muscle Contraction
  • Male